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Abstract: PCNA (proliferating cell nuclear
antigen) immunoreactivity in the uterus of
mature rats was investigated after long term
administration of clomiphene citrate and
ovariectomy.
In the luminal epithelium and glandular
epithelium and endometrial stroma regions,
few PCNA–immunoreactive cells were
observed.
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PCNA reactivity was estimated for the
luminal and glandular epithelium and for the
stromal cells.

Introduction
Immunocytochemical
descriptions
of
PCNA
immunoreactive cells in the mature uterus have been
researched by several researchers (1, 2, 3). Studies have
been done on the effects on the uterus tissue of
non–steroidal
antiestrogens
(species–specific
antiestrogenic and estrogenic effects) (4, 5, 6, 7).
Clomiphene citrate is known to be an ovulation inducer
(8). Therefore, it is an antiestrogen because of its
competitive inhibition of estrogen binding to estrogen
receptors, and it is used as an estrogen antagonist in the
treatment of human breast cancer (9). It is a triphenylene
derivate which has both estrogenic and antagonist
activity, and has the effect of regulating the
hypothalamo–pituitary hormonal release. However, it is
known to have estrogen agonist activity in the
reproductive tracts. Of special interest is the fact that
several clinical studies have found an increased incidence
of endometrial carcinoma (11) and hyperplasia (12) in
long term antiestrogen users. These effects, which have
been observed in postmenopausal women, are thought to
be due to estrogenic stimulation of the endometrium by
antiestrogen.

Treatment of clomiphene citrate decreased
the proliferation of the luminal epithelial cell
and stromal cells to the same extent as
ovariectomy. In both of these groups, the
proportion of anti–PCNA positive cells in the
glandular epithelium was significantly higher
than in the luminal epihelium and stromal
cells. Clomiphene citrate has a strong
antiproliferative effect on the uterus of rats,
and this antiestrogenic action is specific for
cell types.
Key Words: Clomiphene citrate, Uterus,
PCNA immunohistochemistry.

Data derived from these experiments have shown not
only various effects of the drug in different speices, but
also multiple effects on endometrial receptivity,
implantation capacity, egg transport, ovum maturation,
blastocyt development and outcome of pregnanacy (11).
The effects of clomiphene citrate on the genital tract
also depend upon the hormonal status of the subject
under study and the duration of treatment (13).
The effects of estrogen antagonists on the uterus have
been observed in the short–term treatment of immature
or ovariectomized animals a hormonal situation
comparable to that of the postmenopausal woman in
laboratory investigations. In these animal models, they
have been shown to display both weak agonistic and
strong antagonistic actions in rodents. With regard to the
use of Clomiphene citrate as a preventive agent in the
uterine morphology of rats during preimplantation
stages, pregnant animals should be suitable models for
studying the effects of clomiphene citrate on the uterus.
In intact mature rodents, long–term administration of
clomiphene citrate causes a decrease in uterine weight as
in ovariectomized rats (14), but which of the in the
uterine epithelial morphology, the several uterine tissues
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are involved in this antiuterotrophic effect has not
precisely characterized.
The present study was designed to survey the effects
of long–term administration of clomiphene citrate on
proliferation of the uterus in mature rats. We used a
monoclonal antibody against the proliferating cell nuclear
antigen (PCNA) to estimate the proliferative activity in the
luminal and glandular epithelium and in the endometrial
stroma. Untreated mature and ovariectomized rats were
used as controls.
PCNA is an auxilary protein for DNA polymerase delta
(15), and is detectable by immunohistohemistry in cells
which enter the cell cycle at late G1, with the strongest
staining intensity during the S–phase (16).
Materials and Methods
Mature female Wistar rats were used for the present
study. Animals were kept under controlled conditions of
lighting and room temperature. The animals were fed ad
libitum.
Clomiphene citrate (50 mg Clomen tablets, Yurtoğlu
Company, Türkiye) 20 mg/kg/d was dissolved and
administrated by the way of gastric lavage 6 times per
week a period of 8 weeks (n:6). Eight mature female rats
at different stages of the estrus cycle, and 6 rats
ovariectomized in the 8–week period were used as
controls. The animals were sacrificed under ether.
The uterine horns were removed, cut into several
pieces and fixed overnight in 10% formaline solution.
They were passed through an ethanol, xylene series and
embedded in paraffin. The stage of the estrus cycle in the
control animals was ascertained from the vaginal smear
stained with Papanicola methods.
Immunohistochemical detection of PCNA was carried
out with the monoclonal antibody PC10. All sera used
were purchased from Dako. Sections were cut at 3 µm
thickness and mounted on gelatin–coated glass slides,
deparaffinized in three changes of xylol and dehydrated in
graded ethanol. After washing in distilled water, the
sections were placed in 10 mmol citrate buffer, pH 6.0,
and cooked in a pressured cooker for 1 min. Care was
taken to ensure that the sections were always covered
with the buffer. The sections were cooled to room
temperature for 20 min. All the following steps were
carried out at room temparature.
Endogenous peroxidase activity was blocked by
incubating sections with 3% hydrogen peroxide in
methanol 30 min. rabit serum to reduce the unspecific
binding.
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They were then treated with PC10 for 60 min. The
sections were rinsed in PBS and reacted with rabbit
anti–mouse and administratired for 10 min. It was
followed for 10 min by a PAP complex (rabbit: 1/100).
The peroxidase reactions were developed in a solution of
3.3
diaminobenzidine
tetrahydropchloride–H2O2
(0.003% w/v Tris–HCl buffer) for 15 min. Developed
sections were lightly counterstained with Mayer’s
Hematoxylin, dehydrated in a graded series of ethanols,
cleared in xylene and cover–slipped. For positive controls,
sections of human palatine tonsil were used. All sections
were examined with a light microscope.
To estimate the relative frequency of PCNA
immunoreactive cell typs in the luminal and glandular
epithelium, endometrial stromal cells were determined by
counting a total number of 150 cells for each cell type,
per section in a minimum of two sections from different
uterine segments for each animal, and expressing the
PCNA reactivity as the number of positive cells per 50
cells. The cells were counted at a magnification of 1000X.
For statistical analysis of the mean values of the
proliferative reactivity, Student’s t–test was used.
Results
Three immunoreactive cell types (luminal and
glandular epithelium, stromal cells) for PCNA were
identified in the uterus. Immunoreactivity was observed
in positive control sections. Staining with the PCNA
antibody was virtually confined to the nucleus, but did
occasionally overlap into the cytoplasm. Cells with PCNA
reactivity displayed dark homogeneous staining.
The percentage of immunoreactive cells in the uterus
in the experimental group from was different from that
of normal rats. The PCNA immunoreactive cells in the
glandular and luminal epithelium and endometrial stromal
cells were found to be positive in animals treated with
Clomiphene citrate and ovariectomy. However, the
proportion of PCNA immunoreactive cells also varied
considerably between different glandular epithelia in all
the rats examined. Epithelial and stromal cells with
PCNA–positive nuclei were found in all the control group
animals except those in diestrus phase.
Table 1 summarizes the regional distribution and
relative frequency of the PCNA reactive cells in the uterus.
The proliferation was high during proestrus and
metestrus, but intermediate during estrus (Figs 1a, b, c).
In the glandular epthelium, a high proliferation reactivity
was found during metestrus (Fig. 1b), whereas this was
lower during proestrus (Fig. 1a), low and low during
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Table 1.
Experimental group

Control

metestrus
diestrus
proestrus
estrus

Ovariectomy
Clomiphene citrate

n
epithelium

luminal
epithelium

glandular

stromal cell

2
2
2
2
7
6

71.6
0
57.5±7.8
24.2+6.7
1.5+1.1
1.0+1.1

83.5
0
24.4+6.8
5.5+1.6
6.2+4.1
9.2+4.9

4.4
9.4+3.4
3.6+2.9
7.2+3.1
1.3+0.9
0.3+0.3

estrus (Fig. 1c). Rats in diestrus did not display PCNA
immunoreactivity in the luminal and glandular epithelia,
but endometrial connective tissue displayed more

Figure 1.

PCNA immunoreactivity in
the uterus of rats after
control, ovariectomy and
Clomiphene citrate.

anti–PCNA positive nuclei than in the other stages of the
estrus cycle. The highest PCNA activities were found in
the stromal cells in diestrus rats (Fig. 1d).

Immunohistochemical staining for PCNA in the uterus of rats. a) PCNA positive nuclei in the luminal epithelium from a rat in proestrus,
X100. b) Positive cells in the luminal and glandular epithelium from a rat in metestrus, X40. c) A few positive luminal epithelium cells from
a rat in estrus, X100. d) The highest PCNA positive activity in the stromal cells from a rat in diestrus. Luminal epithelial cells are PCNA
negative, X40. le: luminal epithelium, ge: glandular epithelium, s: stroma, f: fibroblast.

395

Immunohistochemical Study on the PCNA–Immunoreactivity in the Uterus of Rats Ovariectomized or Treated With Antiestrogen Clomiphene Citrate

In the ovariectomized rats, PCNA–positive cells were
occasionally observed in the luminal and glandular
epithelia (Fig. 2a). Whereas in some areas, the number of
PCNA positive cells in the glandular epithelium was
significantly lower than in the luminal epithelium (Fig.
2b).

Clomiphene citrate treatment suppressed anti PCNA
immunoreactivity in the uterus. In the luminal epithelium
and endometrial stroma, PCNA reactivities were very low
(Fig. 3a), whereas in the glandular epithelium the
proliferation activity was higher than in the luminal
epithelium and stromal cells (Fig. 3b).

Figure 2.
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Immunochemical staining
for PCNA in the uterus of
rats after ovariectomy. a)
PCNA positive cells are
occasionally observed in
the luminal and glandular
epithelium cells, X40. b)
PCNA positive cells are
lower in the glandular
epithelium than in the
luminal epithelium, X40.
le: luminal epithelium, ge:
glandular epithelium, s:
stroma.
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The mean values of the proliferation activity of
ovariectomized and Clomiphene citrate treated rats
showed no statistical difference (P<0.01).
Discussion
The present immunocytochemistry investigated the
effects of administration of Clomiphene citrate on the
proliferative activity of epithelial and stromal cells in the
uterus of mature rats. Untreated normal and
ovariectomized rats were used as controls.
For the uterus tissue of the rat, PCNA may be suitable
for detection of proliferation.
In the control group, PCNA reactivity varied with the
phases of the estrus cycle. PCNA immunoreactivity in the
epithelial cells in the two rats in diestrus was not present
but the stages of the other estrus cycls in the control
animals, PCNA reactivity was present in the epithelial
cells.
The presence of PCNA–immunoreactive uterine
tissues has been reported. Rumpel et al. in 1994
demonstrated a small number of PCNA immunoreactive
cells in the uterus of mature rats after long–term
administration of tamoxifen (3).
The results of our study demostrate the
antiproliferative effect on the uterus of long term
administration of Clomiphene citrate in mature rats.
Antiproliferative response was strong in the luminal
epithelium and in the endometrial stroma, as shown by
the very low PCNA reactivity and weakness in the gland
epithelium in the same areas. The antiestrogenic effects
were comparable to those of ovariectomy. Rumpel et al.
observed uterine atrophy following long–term treatment
with tamoxifen in adult rats (17). Clomiphene citrate and
its isomers show agonistic and antagonistic effects (18).
That estrogen antagonists inhibit the mitogenic
effects (18) the uterine luminal epithelium to estrogens
has been found during short, term experiments on
immature rats with the antagonists nafoxidine and
clomiphene citrate (19).
In our study, Clomiphene citrate inhibited the
mitogenic responses such that mitotic figures were not
found in the uterus epithelium or glands. There are
differences in the biological properties of the
antiestrogens (20), and the duration of treatment is more
important. Martin (21) has shown that tamoxifen causes
an initial stimulation of stromal mitosis in ovariectomized
rats, but continuing the treatment decreases the number
of proliferating stromal cells.

Figure 3.

The uterus tissue after Clomiphene citrate treatment. a)
Luminal epithelium and endometrial stroma are negative,
X40. b) Many glandular epithelium display PCNA
immunoreactivity whereas luminal epithelium and stromal
cells are negative X40.
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To assess the effects of steroidal antiestrogen on
postnatal uterine development, rats given ICI 182.780 on
postnatal days. Immunocytochemical analysis has revealed
that antiestrogen reduces the uterine estrogen receptor,
and immunoreactivity in all uterine cell types (22).
Poteat WL (1981) has shown that Clomiphene citrate
does not induce glycogen deposition in the uterine luminal
epithelium of pregnant rats as it did in ovariectomized
rats. However, the drug did alter the epithelial
morphology, which may be a factor in its postcoital
contraceptive action (14).
Sato et al. (1996) demostrated that tamoxifen acts as
an estrogen receptor inducer in the uterus and vagina of
neonatal and ovariectomized adult mice (9).

In the uterus of immature or ovariectomized rats,
tamoxifen causes several different estrogenic responses,
such as increase in uterine weight and DNA content. On
the other hand, the drug antagonizes the
estradiol–induced uterine weight gain in ovariectomized
rats (23).
We conclude that the present antiestrogens have
essentially similar effects. Our conclusions are similar to
those previously reported. Therefore, clomiphene citrate
and its isomers have no known long–term effects on the
uterus. Clomiphene citrate has an antiproliferative effect
on the uterine epithelial and stromal cells. This effect is
comparable to that of ovariectomy. Furthermore, the
patterns of antiproliferative activity in luminal and
glandular epithelial cells were observed to differ.
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